First participants with obesity or overweight with at least one weight-related comorbidity have been dosed in a U.S. 13-week Phase IIa study of small ...

The group possessed 50kg of drugs and 1,100 pieces of drug-laced sweets. The suspects allegedly marketed the products through ...

The trial marks a key step in developing a small molecule oral alternative in the booming weight-loss drug market.